160 related articles for article (PubMed ID: 37304545)
1. Prognostic value of prior malignancy history in stage I differentiated thyroid cancer: a SEER-based study.
Wang Y; Li S; Xu F; Hao Q
Transl Cancer Res; 2023 May; 12(5):1241-1253. PubMed ID: 37304545
[TBL] [Abstract][Full Text] [Related]
2. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
[No Abstract] [Full Text] [Related]
3. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
[No Abstract] [Full Text] [Related]
4. Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older.
Wang X; Wu Y; Li X; Hong J; Zhang M
Front Endocrinol (Lausanne); 2023; 14():1132687. PubMed ID: 37033269
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
[TBL] [Abstract][Full Text] [Related]
7. Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer.
Chen YH; Cabanillas M; Sperling J; Xu L; Goswami M; Maniakas A; Williams MD; Lai SY; Busaidy N; Dadu R; Zafereo ME; Wang JR
Thyroid; 2023 Mar; 33(3):321-329. PubMed ID: 36511380
[No Abstract] [Full Text] [Related]
8. The prognostic value of selective neck dissection in early-stage major salivary gland carcinoma: a population-based analysis.
An M; Zuo J; Yuan F; Xiong P
Front Oncol; 2024; 14():1347339. PubMed ID: 38841169
[TBL] [Abstract][Full Text] [Related]
9. Age at Primary Malignancy Determines Survival in Adolescent and Young Adults That Develop a Secondary Thyroid Cancer.
Lau BJ; Goldfarb M
J Adolesc Young Adult Oncol; 2016 Jun; 5(2):201-8. PubMed ID: 27042962
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer.
Dong F; Zhou L; Wang S; Mao J; Liu C; Shi W
Front Endocrinol (Lausanne); 2021; 12():790730. PubMed ID: 35211090
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma.
Wang J; Mao Y; Li L; Liang J; Huang H; Lin W; Chen G; Wen J
Endocrine; 2024 May; ():. PubMed ID: 38809346
[TBL] [Abstract][Full Text] [Related]
14. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
[TBL] [Abstract][Full Text] [Related]
15. Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System.
Liu Z; Chen S; Huang Y; Hu D; Wang M; Wei W; Zhang C; Zeng W; Guo L
Front Oncol; 2019; 9():1093. PubMed ID: 31681617
[No Abstract] [Full Text] [Related]
16. Conditional survival in patients with thyroid cancer.
Banerjee M; Muenz DG; Worden FP; Wong SL; Haymart MR
Thyroid; 2014 Dec; 24(12):1784-9. PubMed ID: 25208475
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in young women: hazards and competing risks after thyroid cancer.
Stroup AM; Harrell CJ; Herget KA
J Cancer Epidemiol; 2012; 2012():641372. PubMed ID: 23091489
[TBL] [Abstract][Full Text] [Related]
18. Analysis of overall survival in differentiated thyroid cancer patients with double primary malignancy.
Wu ST; Chi SY; Wang PW; Chen YN; Yang YT; Chen WC; Chen JF; Chou CK
Kaohsiung J Med Sci; 2021 Jan; 37(1):63-71. PubMed ID: 32841516
[TBL] [Abstract][Full Text] [Related]
19. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
[TBL] [Abstract][Full Text] [Related]
20. Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.
Orosco RK; Hussain T; Brumund KT; Oh DK; Chang DC; Bouvet M
Thyroid; 2015 Jan; 25(1):125-32. PubMed ID: 25369076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]